Monthly Prescribing Reference

FDA Approves Use of Optison in Pediatric Patients With Suboptimal Echocardiograms

Expanding the approval to pediatric patients is expected to improve the diagnostic accuracy of echocardiograms. The Food and Drug Administration (FDA) has approved Optison ™ (perflutren protein-type A ...
Business Wire

GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ultrasound ...
Nasdaq

GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for OptisonTM

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood ...
sciencex

GE Healthcare study supports safety profile of diagnostic heart ultrasound contrast agent Optison

Today, GE Healthcare Medical Diagnostics announced results of a study that evaluated the cardiopulmonary safety of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a ...
Business Wire

GE Healthcare Receives FDA Approval for Change in Contraindications in Prescribing Information for Optison TM

MARLBOROUGH, Mass.--(BUSINESS WIRE)--GE Healthcare announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to remove hypersensitivity to ‘blood and blood ...
Nasdaq

GE HealthCare Announces FDA Approval For Pediatric Use Of Optison Ultrasound Enhancing Agent

(RTTNews) - GE HealthCare (GEHC) announced Tuesday the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company's Optison (Perflutren Protein-Type A Microspheres ...